Official AMFI data
Arthkar
Kotak Mahindra

Kotak Healthcare Fund

Sectoral / ThematicEquity SEBI-regulated

NAV (Direct-Growth)

₹16.8500

As of 3 Jul 2026 · AMFI

AUM

₹560.17 Cr

Expense ratio

0.87%

1Y returns

+20.99%

cat 12.11%

3Y CAGR

cat 22.73%

5Y CAGR

cat 13.72%

Std deviation 3Y

cat 16.29%

In plain English

Kotak Healthcare Fund is a Sectoral / Thematic scheme from Kotak Mahindra. The portfolio is ~99% in equities. Worst historical drawdown: -18% in Mar 2025, recovered in 14 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF174KA1PZ7

NAV (Direct-Growth)

₹16.8500

Last 1Y

+21.08%

Jul 25Min ₹13.04 · Max ₹16.85 · 244 ptsJul 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Mar 2025

-18.0%

Peak ₹14.68 on 2 Jan 2025 → trough ₹12.03 on 3 Mar 2025 (2 months down).

Recovered in 14 months· 4 May 2026

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.87% — typical for category.

  • AUM size

    ₹560 Cr.

  • Sector concentration

    Top 3 sectors = 98.8% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+3.04%+0.29%3/ 18
1M+5.21%+3.93%11/ 18
3M+11.53%+5.61%2/ 18
6M+20.33%+12.10%1/ 18
YTD+21.72%+11.97%1/ 18
1Y+20.99%+12.11%2/ 17
2Y+13.15%+12.10%6/ 14
3Y+22.73%
5Y+13.72%
7Y+19.14%
10Y+13.62%

Portfolio composition

Asset allocation

  • Equity98.84%
  • Cash1.16%

By market cap

  • Large cap32.31%
  • Mid cap22.04%
  • Small cap35.08%
  • Others10.57%

Concentration

Holdings

36

Avg market cap

₹53.4K Cr

Top 10 stocks

55.34%

Top 5 stocks

35.62%

Top 3 sectors

98.84%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 1

    Sun Pharmaceuticals Industries Ltd

    13.91%
  • 1

    Sun Pharmaceuticals Industries Ltd

    13.01%
  • 2

    J.B. Chemicals & Pharmaceuticals Ltd

    7.51%
  • 3

    Max Healthcare Institute Ltd Ordinary Shares

    6.96%
  • 2

    J.B. Chemicals & Pharmaceuticals Ltd

    6.23%
  • 4

    Divi's Laboratories Ltd

    6.05%
  • 3

    Divi's Laboratories Ltd

    5.95%
  • 4

    Max Healthcare Institute Ltd Ordinary Shares

    5.43%
  • 5

    Acutaas Chemicals Ltd

    5.09%
  • 5

    Cipla Ltd

    5.00%
  • 6

    Acutaas Chemicals Ltd

    4.92%
  • 6

    Fortis Healthcare Ltd

    4.67%
  • 7

    Fortis Healthcare Ltd

    4.31%
  • 8

    Park Medi World Ltd

    4.20%
  • 7

    Lupin Ltd

    4.19%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio42.2741.09+1.18
  • P/B ratio5.945.83+0.11
  • Price / Sales6.175.71+0.46
  • Price / Cash Flow31.9230.54+1.38
  • Dividend yield0.52%0.63%-0.11
  • Return on equity (ROE)15.60%16.57%-0.97

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    18.3014.9216.2915.44
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.870.480.980.58
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    1.690.831.710.94
  • Beta

    1 = moves with the market. <1 = less volatile.

    1.070.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.